Lifshitz & Miller LLP Files Amended Shareholder Derivative Lawsuit on Behalf of Dynavax Technologies Corporation

NEW YORK, June 23, 2017 /PRNewswire/ -- Lifshitz & Miller, a law firm focused on representing shareholders nationwide in shareholder derivative litigation and securities class actions, announces that on February 16, 2017, Lifshitz & Miller filed a shareholder derivative action on behalf of Dynavax Technologies Corporation ("Dynavax" or the "Company")(NASDAQ: DVAX).  Lifshitz & Miller filed an amended complaint on May 5, 2017.

If you purchased Dynavax shares at any time prior to June 10, 2013 and still own such shares, and would like additional information about our action, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].  A copy of the complaint is available from Lifshitz & Miller. 

The amended complaint alleges that defendants, officers and directors of the Company, issued materially false and misleading statements and/or omitted material information concerning the true prospects and safety risks of the Company's lead drug candidate – HEPLISAV-B – from approximately April 26, 2012 to November 14, 2016, and that the Company's internal controls over financial reporting are inadequate and deficient. 

On June 7, 2017, the plaintiff in Carol Truglio v. Arnold Oronsky, et al., Case No. RG13686266, a separate derivative case purportedly filed on behalf of Dynavax on July 3, 2013, in the Superior Court of the State of California, Alameda County ("Truglio"), filed a Stipulation of Settlement dated May 19, 2017 (the "Settlement").  On August 8, 2017, Plaintiff in Truglio will be moving for entry of the Proposed Preliminary Approval Order which amongst other things grants preliminary approval of the Settlement.  The relevant time period described in the Settlement is between April 2012 and approximately July 2013.

Lifshitz & Miller has extensive experience representing investors in the prosecution of shareholder derivative litigation and securities class actions in state and federal courts across the country.

ATTORNEY ADVERTISING. © 2017 Lifshitz & Miller LLP.  The law firm responsible for this advertisement is Lifshitz & Miller LLP, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516) 493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz & Miller LLP
Phone:  516-493-9780
Facsimile: 516-280-7376
Email: [email protected]

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lifshitz--miller-llp-files-amended-shareholder-derivative-lawsuit-on-behalf-of-dynavax-technologies-corporation-300479081.html

SOURCE Lifshitz & Miller Law Firm